Danaher Corp
DHRNYSEIndustrial Instruments For Measurement, Display, and ControlFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 26, 2026Last filing: 10-Q on Jul 21, 2026Score 12/3025% above fair value
$227.97−4.26 (-1.83%)
Close on Nov 2, 2026Market cap $160.26BP/E 40.5Yield –
Danaher Life Sciences — Adjusted OP Margin by Quarter
Life Sciences — Adjusted OP Margin (%)
Danaher Life Sciences — Adjusted OP Margin: 21.7% in Q3 2026, up 0.7 pts from a year earlier.
Latest, Q3 2026
21.7%
Period ended Sep 30, 2026
Change on a year earlier
+0.7 pts
21.0% in Q3 2025
History
14 quarters
Since Q2 2023
Sources
10
Documents cited below
Where the Q3 2026 figure comes from
Source: Danaher IR — nongaap_2026Q3 ↗
Reported in Danaher Non-GAAP Reconciliations & Supplemental Data (8-K / IR PDF).
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Life Sciences — Adjusted OP Margin (%) | Year on year | Source |
|---|---|---|---|---|
| Q3 2026 | Sep 30, 2026 | 21.7% | +0.7 pts | Danaher IR — nongaap_2026Q3 ↗ |
| Q2 2026 | Jun 30, 2026 | 21.0% | +1.7 pts | Danaher IR — nongaap_2026Q2 ↗ |
| Q1 2026 | Mar 31, 2026 | 21.7% | +0.9 pts | Danaher IR — nongaap_2026Q1 ↗ |
| Q4 2025 | Dec 31, 2025 | 24.0% | -1.8 pts | Danaher IR — nongaap_2025Q4 ↗ |
| Q3 2025 | Sep 30, 2025 | 21.0% | -1.7 pts | Danaher IR — nongaap_2026Q3 ↗ |
| Q2 2025 | Jun 30, 2025 | 19.3% | -1.8 pts | Danaher IR — nongaap_2026Q2 ↗ |
| Q1 2025 | Mar 31, 2025 | 20.8% | -2.2 pts | Danaher IR — nongaap_2026Q1 ↗ |
| Q4 2024 | Dec 31, 2024 | 25.8% | +3.2 pts | Danaher IR — nongaap_2025Q4 ↗ |
| Q3 2024 | Sep 30, 2024 | 22.7% | -1.7 pts | Danaher IR — nongaap_2025Q3 ↗ |
| Q2 2024 | Jun 30, 2024 | 21.1% | -3.6 pts | Danaher IR — nongaap_2025Q2 ↗ |
| Q1 2024 | Mar 31, 2024 | 23.0% | – | Danaher IR — nongaap_2025Q1 ↗ |
| Q4 2023 | Dec 31, 2023 | 22.6% | – | Danaher IR — nongaap_2024Q4 ↗ |
| Q3 2023 | Sep 30, 2023 | 24.4% | – | Danaher IR — nongaap_2024Q3 ↗ |
| Q2 2023 | Jun 30, 2023 | 24.7% | – | Danaher IR — nongaap_2024Q2 ↗ |
Cite this data
StockData. (2026). Danaher Life Sciences — Adjusted OP Margin (%), quarterly Q2 2023–Q3 2026 [Data set]. Compiled from Danaher SEC filings and investor materials. https://stockdatahq.com/stocks/dhr/kpis/adj-op-margin-lifesci
See every metric in the Danaher KPI table. Data updated Nov 2, 2026.